Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BONESUPPORT HOLDING AB ( (SE:BONEX) ) just unveiled an update.
BONESUPPORT Holding AB has announced a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, while Torbjörn Sköld will take over as CEO starting September 1, 2025. This change is expected to leverage Sköld’s extensive experience in MedTech and orthopedics to further advance the company’s mission and market position. Billbäck’s tenure saw the company grow into a profitable and fast-growing entity, and his continued involvement as a Senior Advisor is anticipated to support Sköld in maintaining the company’s trajectory of innovation and growth.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a leading company in the orthobiologics industry, known for developing and commercializing innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel to the patient’s own bone and have the capability of eluting drugs. The company, based in Lund, Sweden, focuses on transforming outdated standards of care with evidence-based innovations and has achieved significant growth, with net sales amounting to SEK 899 million in 2024.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
See more data about BONEX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue